Integrating significant advances in optical imagining and optical probe technologies to deliver faster diagnosis and treatment of colorectal cancer
Colorectal cancer (CRC) is a major public priority in all countries and at EU level.. When detected early, the 5-year survival rate increases dramatically to 90% compared with only 14% for late stage diagnosis.
Yet today, only 39% of CRC is detected in the early stages.
Funded by the European Commission, the PROSCOPE consortium has worked to achieve important progress in integrating recent advances in optical imaging and optical probe technologies – with the ultimate objective of a single probe platform which can deliver rapid diagnosis and therefore treatment of cancerous polyps.
Our Innovations
The research has shown significant progress in a range of areas. These include:
- The incorporation of novel light sources into endomicroscopic probe heads with unprecedented compatibility with flexible endoscopy in the entire gastrointestinal tract. The new imaging platform has the ability to deliver critical diagnostic information and is now proceeding to in-vivo testing.
- New endoscopy and imaging products which are either in market or close to market, one of which has been awarded ‘Innovation of the Year’ by the European Society of Gastrointestinal Endoscopy.
See the project video to explain the background to the research